DLA Piper advised Intercept Pharmaceuticals on the offering, and Davis Polk advised the sales agent involved.Intercept Pharmaceuticals, Inc. announced the SEC-registered at-the-market offering of its common…
Intercept Pharmaceuticals’ $100 Million Common Stock Offering
